Testing effectiveness (Phase 2)Study completedNCT01863745
What this trial is testing
Nilotinib Roll-over Protocol for Patients in Novartis-sponsored Nilotinib Study and Benefiting From Nilotinib Treatment
Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 15